IS2841B - Samstæða hluta og lyfjasamsetningar - Google Patents

Samstæða hluta og lyfjasamsetningar

Info

Publication number
IS2841B
IS2841B IS6398A IS6398A IS2841B IS 2841 B IS2841 B IS 2841B IS 6398 A IS6398 A IS 6398A IS 6398 A IS6398 A IS 6398A IS 2841 B IS2841 B IS 2841B
Authority
IS
Iceland
Prior art keywords
pharmaceutical compositions
component parts
component
parts
pharmaceutical
Prior art date
Application number
IS6398A
Other languages
English (en)
Other versions
IS6398A (is
Inventor
John Dixon
Ian Kirk
Robert Humphries
Gavin Jarvis
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS6398A publication Critical patent/IS6398A/is
Publication of IS2841B publication Critical patent/IS2841B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
IS6398A 1999-12-01 2002-05-27 Samstæða hluta og lyfjasamsetningar IS2841B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9904377A SE9904377D0 (sv) 1999-12-01 1999-12-01 Pharmaceutical combinations
PCT/SE2000/002378 WO2001039781A1 (en) 1999-12-01 2000-11-29 Pharmaceutical combinations

Publications (2)

Publication Number Publication Date
IS6398A IS6398A (is) 2002-05-27
IS2841B true IS2841B (is) 2013-08-15

Family

ID=20417947

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6398A IS2841B (is) 1999-12-01 2002-05-27 Samstæða hluta og lyfjasamsetningar

Country Status (33)

Country Link
US (2) US20030032618A1 (is)
EP (2) EP1237559B1 (is)
JP (1) JP2003515565A (is)
KR (1) KR100785953B1 (is)
CN (1) CN1402639A (is)
AR (1) AR033658A1 (is)
AT (1) ATE332698T1 (is)
AU (1) AU781691B2 (is)
BR (1) BR0016043A (is)
CA (1) CA2391161C (is)
CO (1) CO5271717A1 (is)
CY (1) CY1105211T1 (is)
CZ (1) CZ300925B6 (is)
DE (1) DE60029340T2 (is)
DK (1) DK1237559T3 (is)
EE (1) EE05127B1 (is)
ES (1) ES2267591T3 (is)
HK (1) HK1047893A1 (is)
HU (1) HU230890B1 (is)
IL (1) IL149495A0 (is)
IS (1) IS2841B (is)
MX (1) MXPA02004871A (is)
MY (1) MY128896A (is)
NO (1) NO331215B1 (is)
NZ (2) NZ518904A (is)
PT (1) PT1237559E (is)
RU (1) RU2242232C2 (is)
SE (1) SE9904377D0 (is)
SI (1) SI1237559T1 (is)
SK (1) SK288707B6 (is)
TW (1) TWI251491B (is)
WO (1) WO2001039781A1 (is)
ZA (1) ZA200203707B (is)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7115585B2 (en) 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
US6897201B2 (en) 2000-08-21 2005-05-24 Inspire Pharmaceuticals, Inc. Compositions and methods for the treatment of glaucoma or ocular hypertension
US7132408B2 (en) 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7452870B2 (en) 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
DE10064797A1 (de) * 2000-12-22 2002-06-27 Knoll Ag Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon
SE0101932D0 (sv) * 2001-05-31 2001-05-31 Astrazeneca Ab Pharmaceutical combinations
US7435724B2 (en) 2002-02-27 2008-10-14 Inspire Pharmaceutical, Inc. Degradation-resistant mononucleoside phosphate compounds
EP1604669A1 (en) * 2004-06-10 2005-12-14 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of ATP analogues for treatment of cardiovascular diseases
JP2009507014A (ja) * 2005-09-21 2009-02-19 チョン クン ダン ファーマセウティカル コーポレイション Ｓ−クロピドグレルの新規レジネート複合体およびその生成法
US9427448B2 (en) 2009-11-11 2016-08-30 The Medicines Company Methods of treating, reducing the incidence of, and/or preventing ischemic events
WO2009140092A1 (en) 2008-05-13 2009-11-19 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
US20120141468A1 (en) 2008-05-13 2012-06-07 Lisa Ruderman Chen Maintenance of platelet inhibition during antiplatelet therapy
US8759316B2 (en) 2008-05-13 2014-06-24 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
US20130303477A1 (en) 2008-05-13 2013-11-14 The Medicines Company Maintenance of Platelet Inhibition During Antiplatelet Therapy
US10376532B2 (en) 2009-11-11 2019-08-13 Chiesi Farmaceutici, S.P.A. Methods of treating, reducing the incidence of, and/or preventing ischemic events
PL2498731T3 (pl) 2009-11-11 2020-07-13 Chiesi Farmaceutici S.P.A. Sposoby leczenia lub zapobiegania zakrzepicy w stencie
JP5947316B2 (ja) 2011-02-09 2016-07-06 ザ メディシンズ カンパニー 肺高血圧症を処置するための方法
CN115120606A (zh) 2013-03-09 2022-09-30 奇斯药制品公司 治疗局部缺血事件、减少局部缺血事件的发生和/或预防局部缺血事件的方法
US11260071B2 (en) 2017-06-23 2022-03-01 Chiesi Farmaceutici S.P.A. Method of preventing of systemic-to-pulmonary-artery shunt thrombosis

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8826448D0 (en) * 1988-11-11 1988-12-14 Thrombosis Res Inst Improvements in/relating to organic compounds
WO1992017488A1 (en) * 1991-04-06 1992-10-15 Fisons Plc Atp analogues
ATE159950T1 (de) * 1993-02-10 1997-11-15 Astra Pharma Prod N-alkyl-2-substituierte atp-analoge
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
SE9404196D0 (sv) * 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation
KR100444123B1 (ko) * 1995-07-11 2004-10-14 아스트라제네카 악티에볼라그 신규한혈소판응집억제제
ES2246575T3 (es) * 1998-06-17 2006-02-16 Bristol-Myers Squibb Company Prevencion del infarto cerebral mediante la administracion de una combinacion de un farmaco antiplaquetario bloqueador del receptor adp y un farmaco antihipertensivo.
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
TWI229674B (en) * 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
US6462021B1 (en) * 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
US6696468B2 (en) * 2002-05-16 2004-02-24 Dainippon Pharmaceutical Co., Ltd. (s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
US20040067995A1 (en) * 2002-10-02 2004-04-08 Wong Pancras C. Novel combination of a factor Xa inhibitor and clopidogrel
JPWO2005007191A1 (ja) * 2003-07-16 2006-08-31 協和醗酵工業株式会社 医薬組成物

Also Published As

Publication number Publication date
US20060270607A1 (en) 2006-11-30
CZ300925B6 (cs) 2009-09-09
IS6398A (is) 2002-05-27
NZ530058A (en) 2005-04-29
NO331215B1 (no) 2011-11-07
CO5271717A1 (es) 2003-04-30
WO2001039781A1 (en) 2001-06-07
EE05127B1 (et) 2009-02-16
CN1402639A (zh) 2003-03-12
MY128896A (en) 2007-02-28
JP2003515565A (ja) 2003-05-07
NO20022606L (no) 2002-07-11
KR100785953B1 (ko) 2007-12-14
NZ518904A (en) 2004-02-27
EP1719526A2 (en) 2006-11-08
HK1047893A1 (en) 2003-03-14
CZ20021887A3 (cs) 2002-11-13
US20030032618A1 (en) 2003-02-13
ATE332698T1 (de) 2006-08-15
EP1719526A3 (en) 2007-04-25
KR20020069201A (ko) 2002-08-29
CA2391161C (en) 2010-10-05
DE60029340D1 (de) 2006-08-24
ES2267591T3 (es) 2007-03-16
SK288707B6 (sk) 2019-10-02
HUP0203585A2 (hu) 2003-03-28
RU2242232C2 (ru) 2004-12-20
AR033658A1 (es) 2004-01-07
DK1237559T3 (da) 2006-10-30
AU1910901A (en) 2001-06-12
IL149495A0 (en) 2004-03-28
PT1237559E (pt) 2006-10-31
ZA200203707B (en) 2003-10-29
DE60029340T2 (de) 2007-07-19
CA2391161A1 (en) 2001-06-07
TWI251491B (en) 2006-03-21
NO20022606D0 (no) 2002-05-31
EE200200271A (et) 2003-06-16
RU2002117296A (ru) 2004-01-20
SE9904377D0 (sv) 1999-12-01
BR0016043A (pt) 2002-07-23
EP1237559A1 (en) 2002-09-11
SI1237559T1 (sl) 2007-02-28
AU781691B2 (en) 2005-06-09
CY1105211T1 (el) 2010-03-03
MXPA02004871A (es) 2002-08-30
SK7502002A3 (en) 2003-02-04
EP1237559B1 (en) 2006-07-12
HU230890B1 (hu) 2018-12-28
HUP0203585A3 (en) 2005-01-28
PL355841A1 (en) 2004-05-17

Similar Documents

Publication Publication Date Title
NO20016277L (no) Systemer og fremgangsmåter for aerolisering av farmasöytiske sammensetninger
DK1329456T3 (da) Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
NO20015175L (no) Farmasöytisk sammensetning
PT1242087E (pt) Composicoes farmaceuticas
DK1242095T3 (da) Antimikrobielle sammensætninger og fremgangsmåder til anvendelse deraf
IS6304A (is) Kínasólínefnasambönd og lyfjafræðilegar efnasamsetningar sem innihalda þau
IS5046A (is) Lyfjasamsetningar
DK1353919T3 (da) Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme
DE69923359D1 (de) Zusammensetzungen und daraus hergestellte gegenstände
NO20000011D0 (no) Skumdempersammensetninger og fremgangsmåter
IL158041A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
IS2841B (is) Samstæða hluta og lyfjasamsetningar
IL161616A0 (en) Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL158044A0 (en) Cyclopropylindole derivatives and pharmaceutical compositions containing the same
IL158300A0 (en) Bisarylimidazol derivatives and pharmaceutical compositions containing the same
IL156812A0 (en) Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
IL157740A0 (en) Heterocyclic derivatives and pharmaceutical compositions containing the same
NO20034778L (no) Farmasöytiske sammensetninger for oral og topisk anvendelse
NO20004277D0 (no) Indolderivater og farmasøytiske sammensetninger omfattende det samme
PT1239832E (pt) Composicoes farmaceuticas
NO20022022D0 (no) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
NO20030156L (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
FI4488U1 (fi) Farmaseuttinen koostumus
IL159085A0 (en) Heterocyclic derivatives and pharmaceutical compositions containing the same